Su\u00e7i\u00e7e\u011fi, her y\u0131l d\u00fcnyadaki milyonlarca \u00e7ocu\u011fu etkiliyor ve bakteriyel enfeksiyonlar veya sinir sistemi hasar\u0131 gibi ciddi komplikasyonlara yol a\u00e7abiliyor. Y\u0131lda 12 milyondan fazla vakan\u0131n kaydedildi\u011fi \u00c7in’de, hastal\u0131k halk sa\u011fl\u0131\u011f\u0131 i\u00e7in b\u00fcy\u00fck bir zorluk te\u015fkil ediyor. Bu duruma kar\u015f\u0131, \u015eenzen \u015fehri, 2019 y\u0131l\u0131nda okul \u00e7a\u011f\u0131ndaki \u00e7ocuklar i\u00e7in \u00fccretsiz su\u00e7i\u00e7e\u011fi a\u015f\u0131s\u0131 program\u0131 ba\u015flatt\u0131. Bu program, korumay\u0131 g\u00fc\u00e7lendirmek amac\u0131yla, ilk dozun 12 ayl\u0131kken, ikinci dozun ise 4 ya\u015f\u0131nda uygulanmas\u0131n\u0131 \u00f6ng\u00f6r\u00fcyor.<\/p>\n
Bu giri\u015fimin sonu\u00e7lar\u0131 dikkat \u00e7ekici. Bu program sayesinde, uygun olan \u00e7ocuklarda su\u00e7i\u00e7e\u011fi vakalar\u0131, uygun olmayanlara k\u0131yasla yakla\u015f\u0131k %23 oran\u0131nda azald\u0131. Ayr\u0131ca, a\u015f\u0131 kapsam\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde artt\u0131: ilk dozun uygulama oran\u0131 %35 artarken, ikinci dozun uygulama oran\u0131 ise %98 gibi etkileyici bir art\u0131\u015f g\u00f6sterdi. Bu rakamlar, finansal engellerin kald\u0131r\u0131lmas\u0131n\u0131n, \u00e7ocuklar\u0131n korunmas\u0131n\u0131 iyile\u015ftirmede kilit bir rol oynad\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n
\u0130ki dozlu \u015feman\u0131n etkinli\u011fi de kan\u0131tland\u0131. \u0130ki doz a\u015f\u0131 olan \u00e7ocuklar\u0131n, tek doz a\u015f\u0131 olanlara k\u0131yasla su\u00e7i\u00e7e\u011fine yakalanma riski %75 daha d\u00fc\u015f\u00fckt\u00fc. Bu fark, ikinci dozun ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131t\u0131n\u0131 g\u00fc\u00e7lendirerek daha sa\u011flam ve uzun s\u00fcreli bir koruma sa\u011flad\u0131\u011f\u0131ndan kaynaklan\u0131yor.<\/p>\n
Bu \u00e7al\u0131\u015fma, \u00fccretsiz ve iki dozlu a\u015f\u0131 programlar\u0131n\u0131n su\u00e7i\u00e7e\u011finin yay\u0131lmas\u0131n\u0131 azaltmada g\u00fc\u00e7l\u00fc bir ara\u00e7 oldu\u011funu do\u011fruluyor. \u015eenzen’de elde edilen sonu\u00e7lar, \u00f6zellikle \u00c7in’in hen\u00fcz ulusal \u00e7apta su\u00e7i\u00e7e\u011fi a\u015f\u0131s\u0131n\u0131n yayg\u0131nla\u015fmad\u0131\u011f\u0131 di\u011fer b\u00f6lgelerine ilham verebilir. B\u00f6yle bir stratejinin benimsenmesi, sadece vaka say\u0131s\u0131n\u0131 azaltmakla kalmayacak, ayn\u0131 zamanda en savunmas\u0131z \u00e7ocuklar\u0131 hastal\u0131\u011f\u0131n a\u011f\u0131r formlar\u0131ndan koruyacakt\u0131r.<\/p>\n
DOI\u00a0:<\/strong> https:\/\/doi.org\/10.1007\/s40121-026-01331-6<\/a><\/p>\n Titre\u00a0:<\/strong> The Impact and Effectiveness of a Two-Dose Varicella Immunization Program Among School Children: Evidence from Quasi-experimental Analyses<\/p>\n Revue : <\/strong> Infectious Diseases and Therapy<\/p>\n \u00c9diteur : <\/strong> Springer Science and Business Media LLC<\/p>\n Auteurs : <\/strong> Huiqiao Gu; Xu Xie; Qiuying Lv; Yuantian Cui; Ziyan Lu; Zaure Akhmetova; Zarina Shulgau; Fang Huang; Yawen Jiang<\/p>\n","protected":false},"excerpt":{"rendered":" \u00dccretsiz a\u015f\u0131 program\u0131, \u00e7ocuklarda su\u00e7i\u00e7e\u011fi vakalar\u0131n\u0131 ger\u00e7ekten azalt\u0131yor mu? Su\u00e7i\u00e7e\u011fi, her y\u0131l d\u00fcnyadaki milyonlarca \u00e7ocu\u011fu etkiliyor ve bakteriyel enfeksiyonlar veya sinir sistemi hasar\u0131 gibi ciddi komplikasyonlara yol a\u00e7abiliyor. Y\u0131lda 12 milyondan fazla vakan\u0131n kaydedildi\u011fi \u00c7in’de, hastal\u0131k halk sa\u011fl\u0131\u011f\u0131 i\u00e7in b\u00fcy\u00fck bir zorluk te\u015fkil ediyor. Bu duruma kar\u015f\u0131, \u015eenzen \u015fehri, 2019 y\u0131l\u0131nda okul \u00e7a\u011f\u0131ndaki \u00e7ocuklar i\u00e7in… Okumaya devam et \u00dccretsiz a\u015f\u0131 program\u0131, \u00e7ocuklarda su\u00e7i\u00e7e\u011fi vakalar\u0131n\u0131 ger\u00e7ekten azalt\u0131yor mu?<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,5,6],"tags":[],"class_list":["post-23","post","type-post","status-publish","format-standard","hentry","category-saglik","category-toplum","category-uluslararasi","entry"],"_links":{"self":[{"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/posts\/23","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/comments?post=23"}],"version-history":[{"count":1,"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/posts\/23\/revisions"}],"predecessor-version":[{"id":24,"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/posts\/23\/revisions\/24"}],"wp:attachment":[{"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/media?parent=23"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/categories?post=23"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepublichealthreview.com\/tr\/wp-json\/wp\/v2\/tags?post=23"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}